Kobo Biotech Ltd-$ share news and announcements

BSE: 531541Chemicals & PetrochemicalsSmall Cap

₹4.10₹0.01 (0.24%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹4.11.

52-week range of traded prices to 23 Oct 2026

₹1.99Low, 11 Dec 2025₹9.99High, 20 Jul 2026

Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.

Market cap: ₹9.77 Cr4,799th largest listed
P/E: No recent results
P/B: No recent results
Dividend yield: Nonein the last 12 months
Volume, BSE: 7,436

Kobo Biotech Ltd-$ share news and announcements

419 announcements, routine notices left out, newest first. Page 2 of 9.

May 2024
- 30 May · Management
  Mr. Abhishek Buddhadev, Non-Executive Independent Director has tendered his resignation w.e.f. 30-05-2024. (opens in a new tab)
- 30 May · Results
  Submission of Audited Financial Results along with the Auditors Report thereon for the auarter and the year ended 31st March, 2024 (opens in a new tab)
- 30 May · Board meeting
  Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Thursday, 30th May, 2024 inter alia approved the audited financial results for the Quarter and the year ended .... (opens in a new tab)
- 23 May · Board meeting
  Meeting on 30 May 2024: audited results
- 23 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve the audited Financial Statement .... (opens in a new tab)
- 17 May · Admission Of Application Under Section 7 Of Insolvency And Bankruptcy Code, 2016 Against M/S. Arch Pharmalabs Limited ("Promoter Entity")
  Admission of Application under Section 7 of Insolvency and Bankruptcy Code, 2016 against M/s. Arch Pharmalabs Limited (Promoter Entity"). (opens in a new tab)
Apr 2024
- 26 Apr · Compliance Certificate Under Regulation 7(3)
  Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations for the year ended 31st March, 2024 (opens in a new tab)
- 20 Apr
  Certificate pursuant to Regulation 40(9) of SEBI LODR (opens in a new tab)
Feb 2024
- 14 Feb · Results
  Financial Results for the Quarter and Nine Months ended 31st December, 2023 (opens in a new tab)
- 7 Feb · Board meeting
  Meeting on 14 Feb 2024: quarterly results
- 7 Feb · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve the unaudited financial statements .... (opens in a new tab)
Nov 2023
- 10 Nov · Related Party Transaction For The Hald Year Ended 30-09-2023
  Related Party Transaction for the Half year ended 30-09-2023 (opens in a new tab)
- 10 Nov · Results
  Board of Director of the company at their meeting held today i.e. 10th November, 2023 inter alia approved the unaudited financials results for the quarter and half year ended 30th September, 2023 (opens in a new tab)
- 3 Nov · Board meeting
  Meeting on 10 Nov 2023: quarterly results
- 3 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 10/11/2023 ,inter alia, to consider and approve the unaudited financial result .... (opens in a new tab)
Oct 2023
- 3 Oct · Meeting
  Voting Results and Scrutinizers Report for the Annual General Meeting of the Company held on 30-09-2023 (opens in a new tab)
Sep 2023
- 30 Sep · Meeting
  Outcome of 30th Annual General Meeting (opens in a new tab)
- 9 Sep · 30Th Annual Report For The Financial Year 2022-23
  We submit herewith the Annual Report of the Company for the Financial Year 2022-23. (opens in a new tab)
- 9 Sep · Meeting
  Notice of the 30th Annual General Meeting of the Company for the Financial Year 2022-23 to be held on Saturday, the 30th day of September 2023 at 10.00 A.M. (opens in a new tab)
Aug 2023
- 11 Aug · Management
  Board of director of the Company has approved the proposal for re-appointment of Ms. Urja Shah as an independent Director for 2nd term of five years, subject to the approval of the members. (opens in a new tab)
- 11 Aug · Results
  Board of Director of the company has approved the Unaudited Financial Result for the quarter ended 30th June, 2023 (opens in a new tab)
- 11 Aug · Results
  This is to inform you that the Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Friday, 11th August, 2023 inter alia approved the Unaudited Financial Results .... (opens in a new tab)
- 3 Aug · Board meeting
  Meeting on 11 Aug 2023: quarterly results
- 3 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 11/08/2023 ,inter alia, to consider and approve This is to inform you that a .... (opens in a new tab)
May 2023
- 30 May · Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2023
  In accordance with Regulation 23(9) of the Listing Regulations, we are enclosing herewith the disclosure of Related Party Transactions for the half year ended 31st March, 2023. (opens in a new tab)
- 30 May · Results
  This is to inform you that the Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Tuesday, 30th May, 2023 inter alia approved the Audited Financial Results of .... (opens in a new tab)
- 30 May · Results
  This is to inform you that the Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Tuesday, 30th May, 2023 inter alia approved the Audited Financial Results of .... (opens in a new tab)
- 24 May · Board meeting
  Meeting on 30 May 2023: audited results
- 24 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve This is to inform you that a .... (opens in a new tab)
Apr 2023
- 18 Apr · Certificate Pursuant To Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended 31St March, 2023
  We enclose herewith a certificate issued by the Practicing Company Secretary, under the captioned regulation, for the half year ended 31st March, 2023. (opens in a new tab)
- 18 Apr · Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March, 2023.
  We enclose herewith the compliance certificate issued jointly by the Company and its Registrar and Share Transfer Agent (RTA) M/s. XL Softech Systems Ltd, under the captioned regulation, .... (opens in a new tab)
- 1 Apr · Meeting
  Result of Postal Ballot by remote e-voting process (opens in a new tab)
Feb 2023
- 27 Feb · Meeting
  Notice of Postal Ballot dated 13th February, 2023. (opens in a new tab)
- 13 Feb · Board meeting
  We wish to inform you that the Board of Directors of the Company at their meeting held today i.e., 13th February 2023, based on the recommendation of the Nomination and Remuneration Committee .... (opens in a new tab)
- 13 Feb · Results
  This is to inform you that the Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Monday, 13th February 2023 inter alia approved the Unaudited Financial Results .... (opens in a new tab)
- 6 Feb · Board meeting
  Meeting on 13 Feb 2023: quarterly results
- 6 Feb · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve the Unaudited Financial Results .... (opens in a new tab)
Nov 2022
- 29 Nov · Disclosure Of Related Party Transactions For The Half Year Ended 30Th September, 2022 Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
  Disclosure of Related Party Transactions for the half year ended 30th September, 2022 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, .... (opens in a new tab)
- 14 Nov · Board meeting
  Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Monday, 14th November, 2022 inter alia approved the Unaudited Financial Results of the Company for the .... (opens in a new tab)
- 7 Nov · Board meeting
  Meeting on 14 Nov 2022: quarterly results
- 7 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve This is to inform you that a .... (opens in a new tab)
Oct 2022
- 18 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 3 Oct · Meeting
  Voting results of the Annual General Meeting held on 30th September, 2022 (opens in a new tab)
Sep 2022
Aug 2022
- 12 Aug · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
  We would like to inform you that with effect from .... (opens in a new tab)
- 11 Aug · Board meeting
  This is to inform you that the Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Thursday, 11th August, 2022 inter alia approved the Unaudited Financial Results .... (opens in a new tab)

Kobo Biotech Ltd-$ share news and announcements

May 2024

Apr 2024

Feb 2024

Nov 2023

Oct 2023

Sep 2023

Aug 2023

May 2023

Apr 2023

Feb 2023

Nov 2022

Oct 2022

Sep 2022

Aug 2022